Biological sex differences in pharmacokinetics and adverse drug reactions
Open accessThe DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
Abstract
Although physiological and hormonal differences between males and females can significantly alter drug absorption, distribution, metabolism, and excretion (ADME), most current pharmacotherapeutic guidelines remain sex neutral. The chapter aims to elucidate biological sex-specific factors across all pharmacokinetic (PK) phases, subsequent therapeutic efficacy, and adverse drug reactions (ADRs), and to highlight implications for individualized therapy including within-woman variation across the menstrual cycle and other hormonal states. This work is based on an extensive review of current literature and clinical data examining sex-specific variations across all phases of pharmacokinetics. Significant biological sex-related differences were found among all PK phases. Females tend to have slower gastric emptying, higher body fat composition, and lower glomerular filtration rates. CYP3A4 is typically more active in females, while CYP1A2, CYP2D6, and CYP2E1 show greater activity in males. In females, endogenous or exogenous hormonal fluctuation can slightly affect gastric motility, protein binding, and selected CYP activities altering clearance for susceptible drugs. In addition, pregnancy increases plasma volume and glomerular filtration with predictable effects on renally cleared drugs and selected hepatic pathways. These differences influence drug half-life, systemic exposure, and the risk of ADRs. Biological sex is a significant determinant of drug pharmacokinetics. Integrating biological sex-specific data into clinical guidelines is essential to optimize drug efficacy and minimize ADRs. Future research and regulatory action should promote biological sex aware pharmacological practices, encouraging routine inclusion of biological sex analyses in clinical trials. Graphical Abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sex differences in pharmacokinetics and plasticity trajectories remain largely unmapped, despite evidence that network biomarkers and treatment prediction are sensitive to demographic and biological heterogeneity [93,232,233,234].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [233]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 1×
“CYP1A2 contributes to 13% of total CYP liver proteins (Shimada et al. 1994) with caffeine, clozapine, erythromycin and propranolol as well-documented substrates (Scandlyn et al. 2008; Thorn et al. 2012; Grzegorze-wski et al. 2021).”
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Sex bias in neuroscience and biomedical research
Beery, A. K., & Zucker, I. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.002 · Cited by 1,763
Sex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163 · cited 4×
“…prolongs the residence time of drugs in the stomach, potentially delaying absorption kinetics (e.g., metoprolol, theophylline, and verapamil) (Soldin and Mattison 2009; Fletcher et al. 1994; Kimura and Higaki 2002; Fleisher et al. 1999; Xiang et al. 2024; Datz et al. 1987; Knight et al.…”
InfluentialSex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Waxman, D. J., & Holloway, M. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056705 · Cited by 815
Clinical pharmacokinetics and pharmacodynamics of propofol
Sahinovic, M. M., Struys, M. M. R. F., & Absalom, A. R. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0672-3 · Cited by 809 · cited 1×
“The Vd of diazepam in females is reported as 1.87 L/kg compared to 1.34 L/kg in males, leading to prolonged drug half-life and extended sedative effects in women (Routledge et al. 1981; Ochs et al. 1981; Greenb-latt et al. 1980; Sahinovic et al. 2018; Hoymork and Raeder 2005).”
InfluentialPharmacokinetics of Monoclonal Antibodies
Ryman, J. T., & Meibohm, B. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12224 · Cited by 802
Almazroo, O. A., Miah, M. K., & Venkataramanan, R. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.001 · Cited by 681
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
Lennard, L., Lilleyman, J. S., Van Loon, J., & Weinshilboum, R. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)91745-v · Cited by 651
Research works printed but not linked: 2
- FDA Drug Safety Communication (2013) FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR [press release]. FDA
- Onetto AJ, Sharif S (2025) Drug distribution. StatPearls. Treasure Island (FL) 33620813
Cited by
Araújo, M. R., Mendes‐Frias, A., & Silvestre, R. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00857-1 · Cited by 12
Wang, F., Li, Y., Feng, X., Shu, Y., Zhang, C., Li, L., & Guo, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149406 · Cited by 4
Seifert, J., Grohmann, R., Toto, S., Reinhard, M. A., Bleich, S., Erfurth, A., Schüle, C., Stübner, S., & Glocker, C. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04900-7 · Cited by 5
Neamah, A. S., & Lafta, F. M. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05046-w · Cited by 2
Medication adherence in adolescents: physiological, psychosocial, and clinical perspectives
Kırmızı, N. İ., Akıcı, N., & Akıcı, A. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05122-1 · Cited by 4
Nastouli, K.-M., Apostolos, A., Bozika, M., Boliaris, G., Iliakis, P., Ktenopoulos, N., Vlachakis, P. K., Karakasis, P., Theodoropoulou, T., Tsiamis, N., et al. (2026) · Medicina · doi:10.3390/medicina62071313 · Cited by 3
Vogt, B. J., Chavez, M., Vélez, N. E. F., Gorashi, R. M., Reeves, R. R., & Shea, L. D. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117678 · Cited by 3
Yang, Y., Xie, Y., Hou, L., & Liu, X. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00973 · Cited by 2
The Impact of Sex on the Dysfunction of Endogenous Pain Control after Traumatic Brain Injury
Irvine, K., Ferguson, A. R., & Clark, J. D. (2026) · Journal of Neurotrauma · doi:10.1177/08977151251413263 · Cited by 1
Huang, B., Gu, S., Wang, S., Ma, Y., Zhou, Y., & Wang, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1761303 · Cited by 1
Sex differences in the disposition of cannabidiol and its metabolites in mice
Olawale, M. E., Lad, M. D., Anyachebelu, M. C., Luo, S., & Lazarus, P. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-026-00427-7 · Cited by 1
Vogt, B. J., Chavez, M., Vélez, N. E. F., Gorashi, R. M., Reeves, R. R., & Aguado, B. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.16.700010 · Cited by 1
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Górawski, F., Joniec‐Maciejak, I., Piechal, A., Pyrzanowska, J., Mirowska-Guzel, D. M., & Blecharz‐Klin, K. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.111937
Yajima, A., & Uesawa, Y. (2026) · Pharmaceuticals · doi:10.3390/ph19030445
Aslam, A., Hong, H., Patterson, T. A., & Guo, W. (2026) · Pharmaceuticals · doi:10.3390/ph19040526 · Cited by 1
Jouanjus, É. (2026) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2026.100786
Giselbrecht, S., & Grant, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.09.723948
Biological sex influences the biodistribution and absorbed dose of 131I (iodide) in mice
Elvborn, M., Ytterbrink, C., Shubbar, E., Spetz, J., Langen, B., & Forssell-Aronsson, E. B. (2026) · Scientific Reports · doi:10.21203/rs.3.rs-9656702/v1
Cohen, T., Rebibo, E., Young, A. H., Schaars, K. K., Juruena, M. F., Schulze, T. G., Kaprio, J. A., van Westrhenen, R., & Shomron, N. (2026) · Pharmaceuticals · doi:10.3390/ph19071028 · Cited by 1
Zhang, X., Lu, W., Zou, D., He, C., Tang, X., Zhu, J., Liao, Z., Feng, H., & Chen, Y.-T. (2026) · Clinical Therapeutics · doi:10.1016/j.clinthera.2026.06.024
Drug-associated bipolar disorder: A disproportionality analysis of the FAERS database
Du, P., Chen, X., Zhang, W., Zhou, Y., & Xu, Y. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117375
Prophylactic Use of NSAIDs in Rugby, Injury Masking and Long-Term Orthopaedic Considerations
Reinert, J. P., Howard, M. S., & Papadimos, T. J. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02602-6
Wang, Z., Yang, K., Wang, L., Zhao, H., Lv, P., Cai, C., Sun, W., & Wang, B. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1861637
Intersectional analysis of patient information leaflets for neglected tropical diseases in Argentina
Bongioanni, A., Gomez, C., Palma, S. D., & Saletti‐Cuesta, L. (2026) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trag107
Habitual coffee consumption is linked to differences in gut microbiota and gut physiology
Bucci, F., Puhlmann, M.-L., Rodríguez-García, P., Yujing, X., Stanstrup, J., Raes, J., Barbera, G. L., Procházková, N., Dragsted, L. O., Laursen, M. F., et al. (2026) · Gut Microbiology · doi:10.1016/j.gutmic.2026.100018
Ma, L., Fan, Y., Gu, R., Li, Z., Liu, Y., Zhang, K., Gao, X., & Zhao, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1889345
Futhey, N. C., Bird, J. D., Neumar, R. W., Robba, C., Olasveengen, T. M., Steele, A. R., Cembrowski, M. S., Hirsch‐Reinshagen, V., & Sekhon, M. S. (2026) · Resuscitation · doi:10.1016/j.resuscitation.2026.111336
Greppmair, S., Pesthy, S., Zöller, M., Scharf, C., Brinkmann, A., Frey, O. R., Zander, J., Liebchen, N., Hagel, S., Wicha, S. G., et al. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00986-26
Luo, K., Zhou, H., Chen, X., Zhang, X., Chen, Y., & Liu, J. (2026) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001536
PARADOX: pharmacological analysis of relation anomalies and drug contradictions extraction
Fata, A., & Rahmani, H. (2026) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-026-00965-5
Shah, M. A. (2026) · Journal of Women s Health Reproductive Medicine and Physiology · doi:10.68041/jwhrmp.v1i1/05
Pharmaceutical Regulation and Women's Health
Krishnappa, R., & Gurugopinath, R. (2026) · IGI Global eBooks · doi:10.4018/979-8-2600-0166-0.ch008
Metadata
- Authors
- Aljohmani, A., & Yildiz, D.
- Affiliations
- Saarland University (DE)
- Corresponding author
- Yildiz, Daniela
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2025-10-21
- Volume
- 399
- Issue
- 3
- Pages
- 3285-3301
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- PMC
- PMC12935741
- OpenAlex
- W4415378844
- Cited by
- 35
- References
- 248
- Citations by year
- 2026: 33 · 2025: 2
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- Universität des Saarlandes
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- sex differences, pharmacokinetics, adverse drug reactions, drug absorption, drug distribution, drug metabolism, drug excretion, CYP enzymes, hormonal fluctuations, menstrual cycle, pregnancy, glomerular filtration rate, gastric emptying, body fat content, personalized treatment
- MeSH terms
- Animals, Cytochrome P-450 Enzyme System, Pharmaceutical Preparations, Female, Humans, Male, Pharmacokinetics, Sex Characteristics, Sex Factors, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.